Mark Massaro
Stock Analyst at BTIG
(4.66)
# 174
Out of 5,090 analysts
170
Total ratings
58.28%
Success rate
23.4%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Reiterates: Buy | $160 | $120.41 | +32.88% | 4 | Dec 3, 2025 | |
| BLLN BillionToOne | Initiates: Buy | $160 | $102.68 | +55.83% | 1 | Dec 1, 2025 | |
| TEM Tempus AI | Maintains: Buy | $96 → $105 | $76.31 | +37.60% | 6 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.15 | - | 20 | Nov 20, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $6 → $7 | $3.65 | +91.61% | 9 | Nov 13, 2025 | |
| PSNL Personalis | Maintains: Buy | $11 → $12 | $10.37 | +15.72% | 3 | Nov 11, 2025 | |
| XGN Exagen | Maintains: Buy | $13 → $15 | $7.50 | +100.00% | 5 | Nov 10, 2025 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $5.05 | +38.61% | 3 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Buy | $210 → $230 | $242.83 | -5.28% | 15 | Nov 7, 2025 | |
| CDNA CareDx | Maintains: Buy | $22 → $25 | $19.31 | +29.47% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $17.31 | +21.32% | 7 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $38 | $39.59 | -4.00% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $785 → $830 | $717.35 | +15.70% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $100 | $108.75 | -8.04% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $165 | $162.17 | +1.75% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.07 | +134.74% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $9.21 | -2.28% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.59 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.70 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $12.13 | +73.20% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.77 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.09 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $127.80 | +134.74% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.86 | -33.20% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $184.18 | -39.19% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $261.48 | -36.90% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $27.82 | +187.56% | 9 | Sep 10, 2018 |
Zoetis
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $120.41
Upside: +32.88%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $160
Current: $102.68
Upside: +55.83%
Tempus AI
Nov 25, 2025
Maintains: Buy
Price Target: $96 → $105
Current: $76.31
Upside: +37.60%
Exact Sciences
Nov 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.15
Upside: -
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $3.65
Upside: +91.61%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $10.37
Upside: +15.72%
Exagen
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $7.50
Upside: +100.00%
SOPHiA GENETICS
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $5.05
Upside: +38.61%
Natera
Nov 7, 2025
Maintains: Buy
Price Target: $210 → $230
Current: $242.83
Upside: -5.28%
CareDx
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $19.31
Upside: +29.47%
Nov 6, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $17.31
Upside: +21.32%
Nov 5, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $39.59
Upside: -4.00%
Nov 4, 2025
Maintains: Buy
Price Target: $785 → $830
Current: $717.35
Upside: +15.70%
Oct 30, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $108.75
Upside: -8.04%
Oct 29, 2025
Maintains: Buy
Price Target: $140 → $165
Current: $162.17
Upside: +1.75%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.07
Upside: +134.74%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $9.21
Upside: -2.28%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $12.13
Upside: +73.20%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.77
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.09
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $127.80
Upside: +134.74%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.86
Upside: -33.20%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $184.18
Upside: -39.19%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $261.48
Upside: -36.90%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $27.82
Upside: +187.56%